These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 35759720)

  • 1. Symptom Clusters and Key Symptoms Among Midlife Perimenopausal and Postmenopausal Women With and Without Metabolic Syndrome.
    Min SH; Yang Q; Docherty SL; Im EO; Hu X
    Nurs Res; 2022 Jul-Aug 01; 71(4):E28-E38. PubMed ID: 35759720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Symptom Clusters Among Midlife Menopausal Women with Metabolic Syndrome.
    Min SH; Docherty SL; Im EO; Yang Q
    West J Nurs Res; 2022 Sep; 44(9):838-853. PubMed ID: 34039103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subgrouping of Japanese middle-aged women attending a menopause clinic using physical and psychological symptom profiles: a cross-sectional study.
    Terauchi M; Hirose A; Akiyoshi M; Owa Y; Kato K; Kubota T
    BMC Womens Health; 2014 Nov; 14():148. PubMed ID: 25420911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical, psychological, and menopause-related symptoms and minor psychiatric disorders in a community-based sample of Brazilian premenopausal, perimenopausal, and postmenopausal women.
    Oppermann K; Fuchs SC; Donato G; Bastos CA; Spritzer PM
    Menopause; 2012 Mar; 19(3):355-60. PubMed ID: 21971211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptoms of depressed mood, disturbed sleep, and sexual problems in midlife women: cross-sectional data from the Study of Women's Health Across the Nation.
    Prairie BA; Wisniewski SR; Luther J; Hess R; Thurston RC; Wisner KL; Bromberger JT
    J Womens Health (Larchmt); 2015 Feb; 24(2):119-26. PubMed ID: 25621768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-reported anxiety, depressive, and vasomotor symptoms: a study of perimenopausal women presenting to a specialized midlife assessment center.
    Seritan AL; Iosif AM; Park JH; DeatherageHand D; Sweet RL; Gold EB
    Menopause; 2010 Mar; 17(2):410-5. PubMed ID: 20216277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and severity of menopause symptoms among perimenopausal and postmenopausal women aged 30-49 years in Gulele sub-city of Addis Ababa, Ethiopia.
    Yisma E; Eshetu N; Ly S; Dessalegn B
    BMC Womens Health; 2017 Dec; 17(1):124. PubMed ID: 29216870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptom experience of Filipino American midlife women.
    Berg JA; Taylor DL
    Menopause; 1999; 6(2):105-14. PubMed ID: 10374216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sleep symptoms during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study.
    Woods NF; Mitchell ES
    Sleep; 2010 Apr; 33(4):539-49. PubMed ID: 20394324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond frequency: who is most bothered by vasomotor symptoms?
    Thurston RC; Bromberger JT; Joffe H; Avis NE; Hess R; Crandall CJ; Chang Y; Green R; Matthews KA
    Menopause; 2008; 15(5):841-7. PubMed ID: 18521049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Midlife women's symptom cluster heuristics: evaluation of an iPad application for data collection.
    Woods NF; Ismail R; Linder LA; Macpherson CF
    Menopause; 2015 Oct; 22(10):1058-66. PubMed ID: 25803668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eszopiclone improves insomnia and depressive and anxious symptoms in perimenopausal and postmenopausal women with hot flashes: a randomized, double-blinded, placebo-controlled crossover trial.
    Joffe H; Petrillo L; Viguera A; Koukopoulos A; Silver-Heilman K; Farrell A; Yu G; Silver M; Cohen LS
    Am J Obstet Gynecol; 2010 Feb; 202(2):171.e1-171.e11. PubMed ID: 20035910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attribution of menopause symptoms in human immunodeficiency virus-infected or at-risk drug-using women.
    Johnson TM; Cohen HW; Howard AA; Santoro N; Floris-Moore M; Arnsten JH; Hartel DM; Schoenbaum EE
    Menopause; 2008; 15(3):551-7. PubMed ID: 18188138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Objective and subjective vasomotor symptom outcomes in the CBT-Meno randomized controlled trial.
    Green SM; Donegan E; McCabe RE; Fedorkow DM; Streiner DL; Frey BN
    Climacteric; 2020 Oct; 23(5):482-488. PubMed ID: 32299247
    [No Abstract]   [Full Text] [Related]  

  • 15. Perimenopause: From Research to Practice.
    Santoro N
    J Womens Health (Larchmt); 2016 Apr; 25(4):332-9. PubMed ID: 26653408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Childhood abuse and vasomotor symptoms among midlife women.
    Carson MY; Thurston RC
    Menopause; 2019 Oct; 26(10):1093-1099. PubMed ID: 31166306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demands for perimenopausal health care in women aged 40 to 60 years-a hospital-based cross-sectional study in Shanghai, China.
    Huang C; Zheng Y; Zhu L; Li Y; Du L; Tao M; Xu B
    Menopause; 2019 Feb; 26(2):189-196. PubMed ID: 30044264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with reporting classic menopausal symptoms differ.
    Duffy OK; Iversen L; Hannaford PC
    Climacteric; 2013 Apr; 16(2):240-51. PubMed ID: 22992029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of high-risk symptom cluster burden group among midlife peri-menopausal and post-menopausal women with metabolic syndrome using latent class growth analysis.
    Min SH; Docherty SL; Im EO; Hu X; Hatch D; Yang Q
    Womens Health (Lond); 2023; 19():17455057231160955. PubMed ID: 36999312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasomotor symptoms are associated with depression in perimenopausal women seeking primary care.
    Joffe H; Hall JE; Soares CN; Hennen J; Reilly CJ; Carlson K; Cohen LS
    Menopause; 2002; 9(6):392-8. PubMed ID: 12439097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.